Previous issues
Volume 23 Issue 4
-
Reviews
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
- Edward Wolfgang Lee, Sarah Khan
- Clin Mol Hepatol. 2017;23(4):265-272.
-
Treatment options after sorafenib failure in patients with hepatocellular carcinoma
- Imane El Dika, Ghassan K. Abou-Alfa
- Clin Mol Hepatol. 2017;23(4):273-279.
-
Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
- Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin
- Clin Mol Hepatol. 2017;23(4):280-289.
-
Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
- Dong Ho Lee
- Clin Mol Hepatol. 2017;23(4):290-301.
-
Histopathological evaluation of liver fibrosis and cirrhosis regression
- Regina C. Lo, Haeryoung Kim
- Clin Mol Hepatol. 2017;23(4):302-307.
-
Editorials
Use of sofosbuvir in chronic kidney disease: Is it necessary?
- Tae Seop Lim, Sang Hoon Ahn
- Clin Mol Hepatol. 2017;23(4):308-310.
-
Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
- Joon Yeul Nam, Jeong-Hoon Lee
- Clin Mol Hepatol. 2017;23(4):311-313.
-
Lamivudine: fading into the mists of time
- Jonggi Choi, Young-Suk Lim
- Clin Mol Hepatol. 2017;23(4):314-315.
-
Original Articles
Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
- Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique
- Clin Mol Hepatol. 2017;23(4):316-322.
-
Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience
- Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim
- Clin Mol Hepatol. 2017;23(4):323-330.
-
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
- Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh
- Clin Mol Hepatol. 2017;23(4):331-339.
-
Case Report
Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review
- Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
- Clin Mol Hepatol. 2017;23(4):340-346.